InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in InMed Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +3 vs. Q4 2021
- Shares held
- 363.1K
- −45.8K (−11.2%) vs. Q4 2021
- Total value
- $341.9K
- −$193.4K (−36.1%) vs. Q4 2021
- New holders
- 4
- 1 more added
- Sold out
- 1
- 3 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $4.18M |
| Q1 2026 | 9 | $206.0K |
| Q4 2025 | 7 | $240.7K |
| Q3 2025 | 9 | $665.2K |
| Q2 2025 | 7 | $28.5K |
| Q1 2025 | 5 | $13.3K |
| Q4 2024 | 5 | $226.7K |
| Q3 2024 | 15 | $266.0K |
| Q2 2024 | 14 | $116.6K |
| Q1 2024 | 18 | $249.2K |
| Q4 2023 | 17 | $334.4K |
| Q3 2023 | 10 | $18.6K |
| Q2 2023 | 10 | $14.5K |
| Q1 2023 | 15 | $109.4K |
| Q4 2022 | 14 | $234.4K |
| Q3 2022 | 15 | $876.9K |
| Q2 2022 | 18 | $514.5K |
| Q1 2022 | 19 | $341.9K |
| Q4 2021 | 18 | $536.4K |
| Q3 2021 | 19 | $979.9K |
| Q2 2021 | 20 | $2.99M |
| Q1 2021 | 22 | $1.55M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding InMed Pharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Advisers, LP | 154,500 | $146.0K | 0.00% | −51,300−24.9% | Reduced |
| Empery Asset Management, LP | 61,741 | $58.0K | 0.27% | +61,741 | New |
| Renaissance Technologies LLC | 45,200 | $43.0K | 0.00% | +1,000+2.3% | Added |
| Two Sigma Investments, LP | 39,700 | $37.0K | 0.00% | −91,973−69.8% | Reduced |
| Two Sigma Securities, LLC | 17,979 | $17.0K | 0.00% | +17,979 | New |
| Geode Capital Management, LLC | 13,905 | $13.0K | 0.00% | +13,905 | New |
| Millennium Management LLC | 14,069 | $13.0K | 0.00% | +14,069 | New |
| Creative Planning | 10,832 | $10.0K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 2,130 | $2.42K | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 545 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,185 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 511 | $482 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 250 | $0 | 0.00% | −151−37.7% | Reduced |
| HC Financial Advisors Inc | 24 | $0 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 347 | $0 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 50 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Gables Capital Management Inc. | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,060−100.0% | Sold out |
| Reilly Financial Advisors, LLC | – | – | – | – | Not filed |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |